Over the past few years, transcatheter valve therapy and heart failure treatment technologies have made significant progress, providing new treatment options for patients who are unresponsive to drug therapy or at high surgical risk/contraindications. At the same time, with the rapid growth in the number and proportion of elderly people, population aging and extended life expectancy will drive demand for medical devices, especially having a positive impact on the field of age-related heart valves and heart failure medical devices. In addition, a series of national incentive policies are also promoting the development of this industry. The government has issued multiple documents encouraging medical device innovation, simplifying approval procedures, and promoting the promotion and application of new medical device technologies. The development and innovation of transcatheter valve therapy and heart failure treatment have received high attention from the government and the medical field, with broad market prospects in the future. For this reason, based on research into this market, Frost & Sullivan (Frost & Sullivan) has released an independent research report titled 'Medical Device Market Study for Transcatheter Valve Therapy and Heart Failure Treatment'.
The attachment is a condensed version of the report. If you have further research needs on China's medical device market for transcatheter valve therapy and heart failure treatment, please contact us:
Mr. Mao from Frost & Sullivan
Tel: (+86)159-2139-6033
E-mail: fred.mao@frostchina.com
